scholarly journals Risk Factors for Periventricular-Intraventricular Hemorrhage in Premature Infants

2010 ◽  
Vol 25 (3) ◽  
pp. 418 ◽  
Author(s):  
Ju Young Lee ◽  
Han Suk Kim ◽  
Euiseok Jung ◽  
Eun Sun Kim ◽  
Gyu Hong Shim ◽  
...  
Vrach ◽  
2021 ◽  
Vol 32 (2) ◽  
pp. 10-16
Author(s):  
O. Zavyalov ◽  
I. Pasechnik ◽  
I. Ignatko ◽  
A. Dementyev ◽  
Zh. Chabaidze ◽  
...  

Author(s):  
Mountasser Mohammad Al-Mouqdad ◽  
Adli Abdelrahim ◽  
Ayman Tagelsir Abdalgader ◽  
Nowf Alyaseen ◽  
Thanaa Mustafa Khalil ◽  
...  

PEDIATRICS ◽  
1984 ◽  
Vol 73 (4) ◽  
pp. 435-439
Author(s):  
Mary P. Bedard ◽  
Seetha Shankaran ◽  
Thomas L. Slovis ◽  
Alfonso Pantoja ◽  
Bimleshwar Dayal ◽  
...  

Forty-two premature infants less than 24 hours of age, with normal admission echoencephalograms, were randomly assigned to control or phenobarbital treatment groups. Infants in the treated group received two loading doses of 10 mg/kg of phenobarbital 12 hours apart, followed by a maintenance dose of 2.5 mg/kg every 12 hours for 6 days. Serial echoencephalograms were obtained in both groups. The groups were comparable with regard to birth weight, gestational age, and potential risk factors for subependymal-intraventricular hemorrhage. Ten infants (48%) in each group developed hemorrhage. The hemorrhages in the phenobarbital-treated group were significantly less severe than those in the control group. The phenobarbital-treated infants who bled, however, were also significantly larger and more mature than control infants who bled. The results of this study indicate no effect of phenobarbital on the incidence of subependymal-intraventricular hemorrhage, but a possible beneficial effect on the severity of hemorrhage.


PEDIATRICS ◽  
1985 ◽  
Vol 76 (3) ◽  
pp. 339-344
Author(s):  
Dilip M. Purohit ◽  
R. Curtis Ellison ◽  
Sally Zierler ◽  
Olli S. Miettinen ◽  
Alexander S. Nadas

The rate of retrolental fibroplasia in relation to prenatal and neonatal characteristics was explored on the basis of a cohort of 3,025 neonates with birth weight less than 1,750 g. The overall rate of retrolental fibroplasia of any degree at hospital discharge was 11%, varying from 43% for those with birth weight between 500 and 749 g to 3% for those in the 1,500- to 1,750-g category. Among the potential determinants, the main interest was in nonhyperoxic characteristics, conditional on measures of prematurity and oxygen supplementation. Maternal diabetes and antihistamine use during the last 2 weeks of pregnancy were associated with significantly higher rates of retrolental fibroplasia, whereas toxemia was associated with lower rates. Frequent apneic spells, bronchopulmonary dysplasia, and sepsis in the neonate were also associated with significantly higher rates. On the other hand, the data indicate no independent role of low Apgar score, intraventricular hemorrhage, exchange transfusion, patent ductus arteriosus, or certain other characteristics previously postulated as risk factors.


Sign in / Sign up

Export Citation Format

Share Document